Literature DB >> 14686757

Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson's disease: a polysomnographic study.

Tomokatsu Yoshida1, Ichiyo Kono, Kenji Yoshikawa, Hiroaki Hashimoto, Hidehiko Harada, Masanori Nakagawa.   

Abstract

An 80-year-old man was admitted to our hospital because of bradykinesia, muscle rigidity and respiratory dysfunction during sleep. Concerning bradykinesia and muscle rigidity, we diagnosed him as the early/moderate stage of Parkinson's disease without autonomic dysfunction. Polysomnography (PSG) showed a series of obstructive hypopneas and apneas. After administration of antiparkinsonian drugs, rigidity of the neck and trunk was diminished along with a drastic decrease in hypopnea on PSG. We consider that sleep hypopnea in this patient is caused by involvement of the striated musculature surrounding the upper-airway and/or rigidity in the trunk. These conditions are treatable with antiparkinsonian drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14686757     DOI: 10.2169/internalmedicine.42.1135

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  Impact of concomitant medications on obstructive sleep apnoea.

Authors:  Ingrid Jullian-Desayes; Bruno Revol; Elisa Chareyre; Philippe Camus; Céline Villier; Jean-Christian Borel; Jean-Louis Pepin; Marie Joyeux-Faure
Journal:  Br J Clin Pharmacol       Date:  2016-11-24       Impact factor: 4.335

Review 2.  Management of sleep disorders in Parkinson's disease and multiple system atrophy.

Authors:  Aleksandar Videnovic
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

3.  Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson's disease.

Authors:  Christianne Martins Corrêa Silva Bahia; João Santos Pereira; Agnaldo José Lopes
Journal:  Sleep Breath       Date:  2018-10-06       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.